While the market for menstrual tracking apps is rapidly growing, there have been no large-scale analyses about why users download these apps, and particularly few studies on their use in the Global South.
Using data from the Google Play Store and Apple App Store between April and December 2021, the study explores why users download these apps in the Global South and North.
Three apps – Clue, Flo and Period Tracker – dominated the market, with over 250 million downloads combined. Most downloads of menstrual tracking apps were concentrated in the Global North, but there were also downloads throughout the Global South, with a particularly high prevalence in South America.
Of the 112 countries included, the study found that low-income countries with a higher unmet need for family planning and higher total fertility rate are associated with more downloads.
Lead author Dr Francesco Rampazzo, Lecturer in Demography at Oxford’s Leverhulme Centre for Demographic Science and Department of Sociology, said, ‘Our findings reinforce emerging evidence that menstrual tracking apps are more popular in areas with limited access to reproductive health services and contraception. This highlights the important role these apps may potentially play in improving access to reproductive health information and services, especially in low-income countries.’
Read the full story on the University of Oxford website.
more recommended stories
Oligometastatic Pancreatic Cancer: New Global ConsensusKey Points Summary An international expert.
Endometriosis Screening Tool May Cut Diagnosis DelaysKey Points Researchers from the University.
Influenza Vulnerability Index Maps Flu Risk Across US StatesKey Points Researchers developed a new.
Post Amputation Pain Patterns Differ by Prosthetic TypeKey Summary A new study from.
Diabetic Kidney Disease: Combo Therapy Targets Zombie CellsKey Points Researchers from Mayo Clinic.
Heart Attack Recovery: Single Injection May Heal the HeartKey Points Researchers have developed a.
Fragmentome Technology Detects Early Liver FibrosisKey Points at a Glance AI-based.
CTNNB1 Syndrome Study Explores Beta-Catenin DefectsKey Takeaways Researchers in Spain are.
Tuberculosis Breakthrough with Experimental AntibioticsKey Takeaways Experimental antibiotics disrupt a.
National Healthy Longevity Trial Receives Federal SupportKey Summary Up to $38 million.
Leave a Comment